General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study

Table 5 NRT regimens prescribed during the second NRT episode, according to year of start of episode

NRT products	Total		2008		2009		2010		2011		2012
	N=	7,868	N=	413	N=	1,518	N=	2,046	N=	2,421	N=	1,470
	n	%	n	%	n	%	n	%	n	%	n	%
Patch only	3,947	50.17	287	69.49	889	58.56	1,021	49.90	1,124	46.43	626	42.59
Patch and gum	293	3.72	14	3.39	61	4.02	97	4.74	81	3.35	40	2.72
Patch and tablet	57	0.72	4	0.97	12	0.79	19	0.93	15	0.62	7	0.48
Patch and inhalator	1,159	14.73	45	10.90	206	13.57	314	15.35	373	15.41	221	15.03
Patch and lozenge	293	3.72	9	2.18	30	1.98	77	3.76	113	4.67	64	4.35
Patch and oral spray	160	2.03	0	0.00	0	0.00	0	0.00	55	2.27	105	7.14
Patch and nasal spray	22	0.28	2	0.48	3	0.20	5	0.24	7	0.29	5	0.34
Other monotherapy*	1475	18.75	41	9.93	265	17.46	405	19.79	481	19.87	283	19.25
Other dual therapy*	165	2.10	5	1.21	19	1.25	40	1.96	61	2.52	40	2.72
≥ 3 types of NRT	297	3.77	6	1.45	33	2.17	68	3.32	111	4.58	79	5.37

*Non-patch products including gum, tablet, inhalator, lozenge, oral spray or nasal spray on their own or in combination with one other non-patch product.

ISSN: 2731-4553